Carboplatin pharmacokinetics in young children with brain tumors.

Tonda, M E; Heideman, R L; Petros, W P; Friedman, H S; Murry, D J; Rodman, J H

Tonda, M E; Heideman, R L; Petros, W P; Friedman, H S; Murry, D J; Rodman, J H.

Affiliation

Tonda ME; Pharmaceutical Sciences Department, St Jude Children's Research Hospital, Memphis, TN 38105, USA.

Cancer Chemother Pharmacol ; 38(5): 395-400, 1996.

Article in En | MEDLINE | ID: mdl-8765431

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Brain Neoplasms/drug therapy; Carboplatin/pharmacokinetics; Adolescent; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics; Carboplatin/administration & dosage; Child; Child, Preschool; Cyclophosphamide/administration & dosage; Etoposide/administration & dosage; Glomerular Filtration Rate/drug effects; Hematologic Diseases/chemically induced; Humans; Prospective Studies; Reproducibility of Results; Statistics, Nonparametric

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carboplatin Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Humans Language: En Journal: Cancer Chemother Pharmacol Year: 1996 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links